TrialCancer discovery2021

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with

Gregory J Riely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.